Streptococcus pneumoniae serotype 4

Streptococcus pneumoniae serotype 4 is a specific variant of the bacterial species *Streptococcus pneumoniae*, distinguished by its unique capsular polysaccharide structure. *S. pneumoniae* is an encapsulated, Gram-positive diplococcus that is part of the normal upper respiratory tract flora but can become pathogenic under certain conditions. The capsule serves as the main virulence factor by protecting the bacterium from phagocytosis and facilitating immune evasion[1][8]. There are over 100 known pneumococcal serotypes defined by their distinct capsular antigens; only some—including serotype 4—are commonly implicated in invasive diseases such as pneumonia, bacteremia, and meningitis[7]. Serotyping is important for epidemiological tracking and vaccine development because different vaccines target specific sets of prevalent disease-causing types[4]. While "serotype 4" refers to a clinically relevant strain group within this species rather than to a single molecular entity typically considered a drug target (such as receptors or enzymes), it remains significant due to its role in human disease and inclusion in pneumococcal conjugate vaccines. Note: "Streptococcus pneumoniae serotype 4" refers to an entire bacterial strain/serogroup rather than a discrete molecular entity typically considered a drug target (such as receptors or enzymes). Therefore, it does not fit standard definitions for therapeutic targets used in drug discovery databases—this makes "is_target" false and "is_incorrect" true according to your conventions.[1][7][8]

Other names

S. pneumoniae serotype 4Pneumococcus serotype 4

Induction of immune response via capsular polysaccharide antigens in vaccines